Visalytics
Visalytics
approved EB-1A RFE Issued

Interventional Cardiologist

Cardiovascular Disease · India · 2025-05-01

Processing Time
118 days
Decision Date
2025-05-01
Location
Arizona
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

3 of 3 criteria met
Scholarly Articles (Met)

The petitioner authored 81 peer-reviewed journal articles and 49 conference abstracts in the field of cardiovascular disease.

Judging (Met)

The petitioner performed over 100 peer reviews for prestigious journals and served on editorial boards.

Original Contributions (Met)

His research on drug-coated balloons and micropuncture access has been implemented in clinical trials and national treatment guidelines.

Why This Petition Was Approved

The approval was based on 81 peer-reviewed articles and 49 conference abstracts with over 1,110 citations, placing the petitioner in the top 1% of his field. He completed over 100 peer reviews for top journals like JACC and served on editorial boards. His innovative techniques, such as micropuncture access, have become standard references in medical literature.

Request for Evidence (RFE)

Successfully Addressed

The RFE challenged the petitioner's sustained international acclaim and the significance of his contributions. The response provided additional documentation of independent citations and proof of the implementation of his techniques in standard clinical practice.

RFE Targets
Original Contributions

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Conference Presentations
Professional Memberships
Judging Experience
Original Contributions
Clinical Deployment
Evidence Submitted
  • 81 peer-reviewed journal articles
  • 49 conference abstracts
  • Over 1,110 citations (top 1% of researchers in cardiovascular medicine)
  • Over 100 peer reviews for journals including JACC: Cardiovascular Interventions and Circulation
  • Editorial Board roles
  • Implementation of findings in clinical trials and multinational treatment protocols
  • Top 10% most-cited publications in clinical medicine for their years

Similar Cases

Clinical Researcher

Healthcare · India

WeGreened EB-1A approved
New York 14 days 2025-03-13
The petition was approved based on meeting multiple EB-1A criteria, including 81 peer-reviewed journal articles and 62 conference abstracts. The applicant demonstrated significant impact through over 800 citations and participation as a judge of others' work with 52 peer reviews. The evidence established the petitioner as an alien of extraordinary ability whose work aligns with public health priorities.
View Case

Cardiologist

Healthcare · India

WeGreened EB-1A approved
Missouri 90 days 2025-10-07
The petition was approved based on the petitioner's 24 peer-reviewed journal articles and 20 conference abstracts, which garnered 436 citations. Additionally, the petitioner demonstrated professional standing by completing 27 peer reviews for top-tier medical journals. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.
View Case

Research Scientist

Healthcare · India

WeGreened EB-1A approved
Ohio 14 days 2025-01-10
The petition was approved based on a high citation impact (over 1,100 citations) and a prolific publication record (54 peer-reviewed articles). The petitioner satisfied the EB-1A criteria through his extensive peer review work (17 reviews), editorial board memberships for three major journals, and original contributions that rank in the top 10% of most-cited papers in Clinical Medicine.
View Case

Postdoctoral Researcher

Healthcare · Japan

WeGreened EB-1A approved
California 60 days 2026-01-05
The petition was approved based on 92 peer-reviewed journal articles, 3 first-authored abstracts, and 2 book chapters. The client documented 2819 citations with strong percentile performance in Clinical Medicine. Additionally, the petitioner completed at least 15 peer reviews for highly selective journals, satisfying the EB-1A criteria for scholarly articles, judging, and original contributions.
View Case

Frequently Asked Questions

A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 118 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 8

EB-1A Case Data

Scraped Case Data

Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299

Related Pages

EB-1A Overview EB-1A in India All EB-1A Cases EB-1A Dashboard

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist